BR0011660A - Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia and, process for the preparation of a compound - Google Patents
Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia and, process for the preparation of a compoundInfo
- Publication number
- BR0011660A BR0011660A BR0011660-2A BR0011660A BR0011660A BR 0011660 A BR0011660 A BR 0011660A BR 0011660 A BR0011660 A BR 0011660A BR 0011660 A BR0011660 A BR 0011660A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treatment
- preparation
- pharmaceutical formulation
- arrhythmia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
"COMPOSTO, FORMULAçãO FARMACêUTICA, USO DE UM COMPOSTO, MéTODO DE PROFILAXIA OU TRATAMENTO DE UMA ARRITMIA E, PROCESSO PARA A PREPARAçãO DE UM COMPOSTO". São fornecidos os compostos da fórmula (I), em que R^ 1^, R^ 2^, R^ 3^, R ^ 4^, R^ 5^, R^ 6^, R^ 7^, R^ 41^, R^ 42^, R^ 43^, R^ 44^, R^ 45^, R^ 46^, A e B têm os significados dados no relatório descritivo, que são úteis na profilaxia e no tratamento de arritmias, em particular nas arritmias atriais e ventriculares."COMPOUND, PHARMACEUTICAL FORMULATION, USE OF A COMPOUND, PROPHYLAXY METHOD OR TREATMENT OF ARRYTHMIA AND PROCESS FOR THE PREPARATION OF A COMPOUND". The compounds of formula (I) are provided, in which R ^ 1 ^, R ^ 2 ^, R ^ 3 ^, R ^ 4 ^, R ^ 5 ^, R ^ 6 ^, R ^ 7 ^, R ^ 41 ^, R ^ 42 ^, R ^ 43 ^, R ^ 44 ^, R ^ 45 ^, R ^ 46 ^, A and B have the meanings given in the specification, which are useful in the prophylaxis and treatment of arrhythmias, in particularly in atrial and ventricular arrhythmias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902268A SE9902268D0 (en) | 1999-06-16 | 1999-06-16 | Pharmaceutically active compounds |
PCT/SE2000/001254 WO2000077000A1 (en) | 1999-06-16 | 2000-06-15 | New bispidine compounds useful in the treatment of cardiac arrhythmias |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0011660A true BR0011660A (en) | 2002-03-26 |
Family
ID=20416100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0011660-2A BR0011660A (en) | 1999-06-16 | 2000-06-15 | Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia and, process for the preparation of a compound |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1192157A1 (en) |
JP (1) | JP2003502329A (en) |
KR (1) | KR20020010713A (en) |
CN (1) | CN1144805C (en) |
AR (1) | AR024577A1 (en) |
AU (1) | AU761576B2 (en) |
BR (1) | BR0011660A (en) |
CA (1) | CA2375841A1 (en) |
CZ (1) | CZ20014495A3 (en) |
EE (1) | EE200100675A (en) |
HK (1) | HK1045520A1 (en) |
HU (1) | HUP0203959A3 (en) |
IL (1) | IL146754A0 (en) |
IS (1) | IS6201A (en) |
MX (1) | MXPA01012919A (en) |
NO (1) | NO20016117L (en) |
NZ (1) | NZ516013A (en) |
PL (1) | PL354032A1 (en) |
RU (1) | RU2250903C2 (en) |
SE (1) | SE9902268D0 (en) |
SK (1) | SK18272001A3 (en) |
TR (1) | TR200103663T2 (en) |
WO (1) | WO2000077000A1 (en) |
ZA (1) | ZA200109796B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030302A1 (en) * | 2000-07-07 | 2003-08-20 | Astrazeneca Ab | BISPIDINE COMPOUNDS, PHARMACEUTICAL FORMULATION, USE FOR THE MANUFACTURE OF MEDICINES, PROCESS FOR THE PREPARATION OF THESE INTERMEDIATE COMPOUNDS AND COMPOUNDS |
SE0101327D0 (en) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New crystalline forms |
TWI499418B (en) * | 2009-05-21 | 2015-09-11 | Nerviano Medical Sciences Srl | Isoquinolin-1(2h)-one derivatives |
DK2729444T3 (en) * | 2011-07-08 | 2017-12-04 | Bayer Ip Gmbh | METHOD FOR PREPARING 2-AMINO-5-CYANO-N, 3-DIMETHYLBENZAMIDE |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT88381B (en) * | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | PROCESS FOR THE PREPARATION OF NEW COMPOUNDS 3,7-DIAZABICYCLO (3,3,1) NONANO, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
DE3732094A1 (en) * | 1987-09-24 | 1989-04-06 | Basf Ag | BISPID DERIVATIVES AS CLASS III ANTIARRHYTHMICS |
US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
US5468858A (en) * | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
SE9704709D0 (en) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
-
1999
- 1999-06-16 SE SE9902268A patent/SE9902268D0/en unknown
-
2000
- 2000-06-15 IL IL14675400A patent/IL146754A0/en unknown
- 2000-06-15 JP JP2001503858A patent/JP2003502329A/en active Pending
- 2000-06-15 CA CA002375841A patent/CA2375841A1/en not_active Abandoned
- 2000-06-15 NZ NZ516013A patent/NZ516013A/en unknown
- 2000-06-15 MX MXPA01012919A patent/MXPA01012919A/en unknown
- 2000-06-15 CN CNB008116962A patent/CN1144805C/en not_active Expired - Fee Related
- 2000-06-15 WO PCT/SE2000/001254 patent/WO2000077000A1/en not_active Application Discontinuation
- 2000-06-15 RU RU2001132563/04A patent/RU2250903C2/en not_active IP Right Cessation
- 2000-06-15 CZ CZ20014495A patent/CZ20014495A3/en unknown
- 2000-06-15 HU HU0203959A patent/HUP0203959A3/en unknown
- 2000-06-15 KR KR1020017016168A patent/KR20020010713A/en not_active Application Discontinuation
- 2000-06-15 SK SK1827-2001A patent/SK18272001A3/en unknown
- 2000-06-15 EE EEP200100675A patent/EE200100675A/en unknown
- 2000-06-15 PL PL00354032A patent/PL354032A1/en not_active Application Discontinuation
- 2000-06-15 EP EP00946589A patent/EP1192157A1/en not_active Withdrawn
- 2000-06-15 TR TR2001/03663T patent/TR200103663T2/en unknown
- 2000-06-15 AU AU60324/00A patent/AU761576B2/en not_active Ceased
- 2000-06-15 BR BR0011660-2A patent/BR0011660A/en not_active IP Right Cessation
- 2000-06-16 AR ARP000103015A patent/AR024577A1/en not_active Application Discontinuation
-
2001
- 2001-11-28 ZA ZA200109796A patent/ZA200109796B/en unknown
- 2001-12-14 NO NO20016117A patent/NO20016117L/en not_active Application Discontinuation
- 2001-12-14 IS IS6201A patent/IS6201A/en unknown
-
2002
- 2002-09-27 HK HK02107165.2A patent/HK1045520A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ516013A (en) | 2003-06-30 |
NO20016117L (en) | 2002-02-15 |
NO20016117D0 (en) | 2001-12-14 |
AU6032400A (en) | 2001-01-02 |
MXPA01012919A (en) | 2002-07-30 |
CN1144805C (en) | 2004-04-07 |
CN1370167A (en) | 2002-09-18 |
SK18272001A3 (en) | 2002-12-03 |
ZA200109796B (en) | 2003-02-28 |
IL146754A0 (en) | 2002-07-25 |
IS6201A (en) | 2001-12-14 |
HK1045520A1 (en) | 2002-11-29 |
HUP0203959A3 (en) | 2003-04-28 |
RU2250903C2 (en) | 2005-04-27 |
AU761576B2 (en) | 2003-06-05 |
EP1192157A1 (en) | 2002-04-03 |
AR024577A1 (en) | 2002-10-16 |
HUP0203959A2 (en) | 2003-03-28 |
WO2000077000A1 (en) | 2000-12-21 |
TR200103663T2 (en) | 2002-05-21 |
SE9902268D0 (en) | 1999-06-16 |
JP2003502329A (en) | 2003-01-21 |
KR20020010713A (en) | 2002-02-04 |
CA2375841A1 (en) | 2000-12-21 |
CZ20014495A3 (en) | 2002-05-15 |
EE200100675A (en) | 2003-02-17 |
PL354032A1 (en) | 2003-12-15 |
WO2000077000A9 (en) | 2003-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0014804A (en) | Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia, and, process for the preparation of a compound | |
BR9813668A (en) | Compound, use of the same, process to prepare it, pharmaceutical formulation, and, prophylaxis or treatment of an arrhythmia | |
BR0016678A (en) | Compound, pharmaceutical formulation, use of a compound, method for prophylaxis or treatment of an arrhythmia, and, process for preparing a compound | |
CY1106178T1 (en) | 2'- SUBSTITUTED 1,1'-BIPHENYL-2-CARBOXAMIDES, METHOD FOR THEIR PREPARATION, THEIR USE AS A MEDICINE AS WELL AS PHARMACEUTICAL PREPARATIONS COMPRISING THEM | |
BR0206791A (en) | Compound, pharmaceutical formulation, use of a compound, method of prophylaxis or treatment of an arrhythmia, and process for the preparation of a compound | |
NO883073D0 (en) | 3-DESMETHYL-MEVALONIC ACID DERIVATIVES, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATE PRODUCTS. | |
BR9911482A (en) | Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
AR031430A1 (en) | ORIS BISARILO COMPOUNDS, META-SUBSTITUTES, PROCEDURES FOR THEIR PREPARATION, ITS USE AS A MEDICINAL PRODUCT AS ALSO THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
BRPI0713457A2 (en) | compound, use thereof, pharmaceutical composition, method of treating arrhythmias, agent for treating arrhythmias, and process for preparing a compound | |
BR9714082A (en) | Compound, use thereof, pharmaceutical composition, and, processes for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound. | |
BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
BR9907270A (en) | Compound, pharmaceutical composition, use of a compound, and, processes for the treatment or prophylaxis of inflammatory diseases, for example, asthma or copd, and for the preparation of a compound | |
BR0014695A (en) | 5- (2-substituted-5-heterocyclylsulfonylpyrid-3-yl) -dihi dropirazolo [4,3-d] pyrimidin-7-ones as phosphodiesterase inhibitors | |
BRPI0312464B8 (en) | tyrosine kinase inhibitor compounds, pharmaceutical compositions comprising them, processes for manufacturing and uses thereof | |
YU88801A (en) | Indanyl-substituted benzole carbonamide, mathod for the production of the same, use thereof as a medicament and pharmaaceutical preparations containing same | |
BR0014060A (en) | Quinolyl propyl piperidine derivative, process for preparing it and pharmaceutical composition | |
BR0309546A (en) | A compound, a pharmaceutical composition comprising the same, a process for its preparation and use and a method for the prophylactic or therapeutic treatment of type II diabetes. | |
BR0116369A (en) | Compound, method for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, use of a compound, and, process for preparing compound | |
BR0114321A (en) | Compound, pharmaceutical composition, use of a compound, method of treating or prophylaxis of inflammatory diseases, and process for preparing a compound | |
BR0108694A (en) | Malnic acid derivatives, process for preparing them, use of them as an inhibitor of factor xa activity and pharmaceutical compositions containing the same | |
BR9100938A (en) | COMPOSITION THAT UNDERSTANDS AN ELASTASE INHIBITOR, BENZISOTIAZOLINONE 1-DIOXIDE DERIVATIVES AND COSMETIC TREATMENT PROCESS | |
RU95111308A (en) | Derivatives of 2-amino-4-phenyl-4-oxobutyric acid, methods of synthesis, pharmaceutical composition | |
PT952974E (en) | BIPHENYLIC DERIVATIVES SUBSTITUTED BY AN AROMATIC OR HETEROAROMATIC RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM | |
BR9803968A (en) | Biphenylsulfonylcyanamides, process for their preparation and use as a medicine. | |
MX9300708A (en) | LIPOSOMATIC COMPOSITIONS TOPICS INCLUDING ITRACONAZOLE AND PROCEDURE FOR ITS PREPARATION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |